19 reports

  • 4.1.1 VRS-317 - THE US GROWTH HORMONE DEFICIENCY MARKET
  • PERCENTAGE OF PEDIATRIC & ADULT GHD PATIENTS TREATED WITH GROWTH HORMONE (2017/2020)

Human growth hormone is produced by the pituitary gland and it spurs growth in children and adults. It regulates body fluids, muscle and bone growth and fat metabolism of the body. Growth hormone is important for normal functioning in humans. The deficiency of growth hormone is termed as Growth Hormone Deficiency (GHD)...

  • Growth Hormone
  • World
  • Eli Lilly & Co.
  • Novartis AG
  • Novo Nordisk Group

GLOBAL GROWTH HORMONE DRUGS MARKET FORECAST TO 2027 ##.

  • Biopharmaceutical
  • Biotechnology
  • Growth Hormone
  • World
  • Market Shares

Healthcare Epidemiology Forecast to 2026 EPICAST REPORT: GROWTH HORMONE DEFICIENCY Report Code: Published: GDHCER##-## June 2017 ## ## ## Executive Summary GROWTH HORMONE DEFICIENCY (GHD) IS CHARACTERIZED BY LOW SECRETION OF GROWTH

  • Growth Hormone
  • Japan
  • United States
  • World
  • Forecast
  • TREATMENT GUIDELINES FOR GROWTH HORMONE DEFICIENCY
  • Growth Hormone Deficiency Treatment Algorithm

OpportunityAnalyzer: Growth Hormone Deficiency - Opportunity Analysis and Forecasts to 2026 Summary Growth hormone deficiency (GHD) is a rare endocrine disorder characterized by inadequate secretion of growth hormone (GH), also called Somatropin, from the anterior pituitary gland located at the base of the brain (NORD,...

  • Growth Hormone
  • Somatropin
  • Novo Nordisk Group
  • Pfizer Inc.
  • Versartis, Inc.

Growth Hormone Deficiency (GHD) -Epidemiology Forecast to 2027 ##.

  • Growth Hormone
  • France
  • Germany
  • Italy
  • Spain

Growth Hormone Deficiency (GHD) - Market Insight, Epidemiology and Market Forecast - 2027 ##.

  • Biological Therapy
  • Biopharmaceutical
  • Biotechnology
  • Growth Hormone
  • United States
  • Abbreviations and Acronyms used in the report

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Growth Hormone Deficiency (GHD) in 9 Major Markets Growth Hormone Deficiency (GHD) results from the destruction of normal pituitary and hypothalamic tissue and is characterized by the inadequate secretion of growth hormone (GH), from the anterior pituitary gland....

  • Growth Hormone
  • Pathology
  • Growth Hormone Deficiencies
  • 5.3 GROWTH HORMONE DEFICIENCIES BIOSIMILARS MARKET AND FORECAST

The biosimilars are poised to capture an unprecedented position in the biopharmaceutical industry driven by an increased extent of adoption and growing investment and deal making activity globally. The global biosimilars market is predicted to cross US$ 25 Billion mark by 2020. With the continuous increasing demand for biologics,...

  • Growth Hormone
  • World
  • Market Size
  • Amgen Inc.
  • Biocon Limited
  • GROWTH HORMONE DEFICIENCY - LATE STAGE PIPELINE, 2014
  • GROWTH HORMONE DEFICIENCY: KEY METRICS IN THE 7MM, 2014-2024

Opportunity Analyzer: Growth Hormone Deficiency - Opportunity Analysis and Forecast to 2024 Summary GlobalData estimates the 2014 sales for growth hormone deficiency (GHD) at approximately $1.26 billion across the 7MM covered in this report. The market will grow moderately at a CAGR of 4.08% during the 10-year forecast...

  • Growth Hormone
  • Japan
  • United States
  • Novo Nordisk Group
  • Pfizer Inc.
  • Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) - Dormant Products
  • Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) - Discontinued Products

Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) – Pipeline Review, H1 2018 Summary According to the recently published report ’Growth Hormone Secretagogue Receptor Type 1 – Pipeline Review, H1 2018’; Growth Hormone Secretagogue Receptor Type...

  • Growth Hormone
  • United States
  • World
  • Product Initiative
  • Helsinn Group
  • Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) - Discontinued Products
  • Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) - Dormant Products

Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) - Pipeline Review, H2 2017 Summary Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) - Growth hormone secretagogue receptor (GHSR) also known as ghrelin receptor,...

  • Growth Hormone
  • United States
  • World
  • Product Initiative
  • Helsinn Group
  • GROWTH HORMONE DEFICIENCY THERAPEUTICS, E7 COUNTRIES, CLINICAL TRIALS BY PHASE, 2017*
  • GROWTH HORMONE DEFICIENCY THERAPEUTICS, GLOBAL, CLINICAL TRIALS IN PROGRESS BY PHASE, 2017*

Growth Hormone Deficiency Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Growth Hormone Deficiency Global Clinical Trials Review, H2, 2017" provides an overview of Growth Hormone Deficiency clinical trials scenario. This report provides top line data relating...

  • Biopharmaceutical
  • Clinical Trial
  • Growth Hormone
  • World
  • Product Initiative
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2016
  • NUMBER OF PRODUCTS BY STAGE AND MECHANISM OF ACTION, H1 2016

Growth Hormone Secretagogue Receptor Type 1 (GHS-R or GH-Releasing Peptide Receptor or GHRP or Ghrelin Receptor or GHSR) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Growth Hormone Secretagogue Receptor Type 1 (GHS-R or GH-Releasing Peptide Receptor or GHRP or Ghrelin Receptor or GHSR) - Pipeline Review,...

  • Growth Hormone
  • Therapy
  • World
  • Product Initiative
  • Helsinn Group
  • Growth Hormone Deficiency Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Growth Hormone Deficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*

Growth Hormone Deficiency Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Growth Hormone Deficiency Global Clinical Trials Review, H1, 2015" provides an overview of Growth Hormone Deficiency clinical trials scenario. This report provides top line data relating to the clinical trials...

  • Clinical Trial
  • Drug Discovery And Development
  • Growth Hormone
  • World
  • Market Size
  • Growth Hormone Deficiency Overview
  • Growth Hormone Deficiency - Dormant Projects

Growth Hormone Deficiency - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Growth Hormone Deficiency - Pipeline Review, H2 2015’, provides an overview of the Growth Hormone Deficiency’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Growth Hormone...

  • Biopharmaceutical
  • Growth Hormone
  • United States
  • World
  • Product Initiative
  • Official Title

Hypopituitarism Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Hypopituitarism Global Clinical Trials Review, H2, 2017" provides an overview of Hypopituitarism clinical trials scenario. This report provides top line data relating to the clinical trials on Hypopituitarism. Report...

  • Endocrine Disease
  • Growth Hormone
  • World
  • Product Initiative
  • F. Hoffmann-La Roche Ltd.
  • Official Title
  • Clinical Trial profile. 10 Trial Title

Idiopathic Short Stature Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Idiopathic Short Stature Global Clinical Trials Review, H2, 2017" provides an overview of Idiopathic Short Stature clinical trials scenario. This report provides top line data relating to the clinical trials...

  • Growth Hormone
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative

TITLE: DESIGN AND CLINICAL DEVELOPMENT OF TRANSCON GROWTH HORMONE FOR GROWTH HORMONE DEFICIENCY DATE: SATURDAY, APRIL ##, 2017 TIME: ##:## - ##:## PM POSTER: SAT ## TITLE: USER DRIVEN DEVELOPMENT OF A NEW DEVICE FOR WEEKLY GROWTH

  • Growth Hormone
  • United States
  • Company
  • Corporate Finance
  • Product Initiative
  • BBT-031
  • Bolder Biotechnology, Inc., Key Facts

Bolder Biotechnology, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Bolder Biotechnology, Inc. - Product Pipeline Review - 2016’, provides an overview of the Bolder Biotechnology, Inc.’s pharmaceutical research and development focus. The report provides comprehensive information on the...

  • Growth Hormone
  • Research And Development
  • United States
  • Company Operations
  • Bolder BioTechnology, Inc.